About Anthea Pharma
Anthea Pharma is a Healthcare company based in Hyderabad (India). It provides comprehensive services in formulation development, marketing, quality management, and regulatory support for pharmaceuticals. It operates on a B2B model. The company has 460 employees. Its focus areas include Pharmaceuticals, Drug Development and Regulatory and Marketing Services. Its competitors include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus and 4 more; 2 of its 9 listed competitors have raised funding.
Company details
Anthea Pharma provides comprehensive services in formulation development, marketing, quality management, and regulatory support for pharmaceuticals, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and regulatory and marketing services. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Hyderabad, India
- Employees 460
- SectorsHealthcare
- Website antheapharma.com
- Social X
- Annual Revenue$56.86 K (USD)0as on Mar 31, 2022
- Employee Count460
Associated legal entities of Anthea Pharma
Anthea Pharma is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avalok Consultancy Llp CIN ACA-6788 | Active | 20 Apr 2023 | Hyderabad, Telangana | – | – | 2 | View details |
| Anthea Pharma Private Limited CIN U24304TG2019PTC136590 | Active | 05 Nov 2019 | Hyderabad, Telangana | ₹27.8 Cr | 507 | 3 | View details |
Board of directors of Anthea Pharma
The boards of the 2 registered companies of Anthea Pharma currently have 3 directors; the longest-serving is Pavan Kumar Gorukanti, appointed in 2020. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pavan Kumar Gorukanti DIN 01660582 | Director | 31 Aug 2020 | 6 yrs 1 mo | Anthea Pharma Private Limited |
| Aishwarya Rao Dhannapuneni DIN 07210398 | Designated Partner | 20 Apr 2023 | 3 yrs 6 mo | Avalok Consultancy Llp |
| Abhinav Gorukanti DIN 03155834 | Designated Partner | 20 Apr 2023 | 3 yrs 6 mo | Avalok Consultancy Llp, Anthea Pharma Private Limited |
Financials of Anthea Pharma
Figures of Anthea Pharma Private Limited, the primary company behind Anthea Pharma, for FY 2025. Revenue was ₹27.78 Cr (+516% year on year). Net loss was -₹6.10 Cr (-22% margin). EBITDA was ₹4.86 Cr (18% margin). Revenue has grown at a compounded annual rate of +296% over three years.
- ₹27.78 CrRevenue · FY 2025 · +516% YoY
- -₹6.10 CrNet loss · -22% margin
- ₹4.86 CrEBITDA · 18% margin
- ₹310 CrPaid-up capital
- 507Employees (provident fund records)
- +296%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Anthea Pharma Private Limited are on its company page.
Detailed financial statements for Anthea Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Anthea Pharma
Anthea Pharma has 9 listed competitors in our database, 2 of them funded. They include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas | |
| cms.net.cn | 1992 | Shenzhen, China | – | – | Generic formulations including tablets, capsules, liquids, and injectables are manufactured. |
Detailed competitors of Anthea Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Anthea Pharma
The website of Anthea Pharma (antheapharma.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 26% vs previous month
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Anthea Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Anthea Pharma
Anthea Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Anthea Pharma has 460 employees.
Annual revenue of Anthea Pharma is $56.86K as on Mar 31, 2022.
Anthea Pharma provides comprehensive services in formulation development, marketing, quality management, and regulatory support for pharmaceuticals, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and regulatory and marketing services. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Anthea Pharma's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Anthea Pharma is associated with 2 legal entities: Avalok Consultancy Llp, Anthea Pharma Private Limited.
The legal entities of Anthea Pharma currently have 4 directors, including Aishwarya Rao Dhannapuneni, Abhinav Gorukanti, Pavan Kumar Gorukanti and others.